Operon Biotechnologies Overview

  • Founded
  • 1986
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Operon Biotechnologies General Information

Description

Supplier of synthetic DNA oligonucleotides. The company offers a wide range of oligos, probes and primers, as well as longmers and modified oligos.

Contact Information

Website
www.operon.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
MWG Biotech
Primary Office
  • 2211 Seminole Drive
  • Huntsville, AL 35805
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Operon Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Operon Biotechnologies‘s full profile, request access.

Request a free trial

Operon Biotechnologies Patents

Operon Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20090203897-A1 Method of using polymer embedded solid supports for small scale oligonucleotide synthesis Abandoned 08-Feb-2008 000000000 0
US-20070253870-A1 Specimen tube holder and shipping container Abandoned 01-May-2006 00000000 00
US-20040241872-A1 Liquid aspirating, dispensing, mixing, transferring and reacting device comprising ultraviolet and/or visible spectral analytical tools for monitoring and sceening nucleic acid products Abandoned 17-Mar-2003 G01N35/1065 00